Comparison between Affle IPO and Neogen Chemicals IPO.
Affle IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Neogen Chemicals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Affle IPO is up to ₹459.00 Cr whereas the issue size of the Neogen Chemicals IPO is up to ₹132.35 Cr. The final issue price of Affle IPO is ₹745.00 per share and of Neogen Chemicals IPO is ₹215.00 per share.
| Affle IPO | Neogen Chemicals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹740.00 per share | ₹212.00 per share |
| Issue Price (Upper) | ₹745.00 per share | ₹215.00 per share |
| Issue Price (Final) | ₹745.00 per share | ₹215.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 20 shares | 65 shares |
| Fresh Issue Size | 12,08,053 shares | 32,55,813 shares |
| Fresh Issue Size (Amount) | up to ₹90.00 Cr | up to ₹70.00 Cr |
| OFS Issue Size | 49,53,020 shares | 29,00,000 shares |
| OFS Issue Size (Amount) | up to ₹369.00 Cr | up to ₹62.35 Cr |
| Issue Size Total | 61,61,073 shares | 61,55,813 shares |
| Issue Size Total (Amount) | up to ₹459.00 Cr | up to ₹132.35 Cr |
Affle IPO opens on Jul 29, 2019, while Neogen Chemicals IPO opens on Apr 24, 2019. The closing date of Affle IPO and Neogen Chemicals IPO is Jul 31, 2019, and Apr 26, 2019, respectively.
| Affle IPO | Neogen Chemicals IPO | |
|---|---|---|
| Anchor Bid Date | Jul 26, 2019 | Apr 23, 2019 |
| Issue Open | Jul 29, 2019 | Apr 24, 2019 |
| Issue Close | Jul 31, 2019 | Apr 26, 2019 |
| Basis Of Allotment (Tentative) | Aug 05, 2019 | May 03, 2019 |
| Initiation of Refunds (Tentative) | Aug 06, 2019 | May 06, 2019 |
| Credit of Share (Tentative) | Aug 07, 2019 | May 07, 2019 |
| Listing date (Tentative) | Aug 08, 2019 | May 08, 2019 |
| Anchor Lockin End date 1 | Sep 04, 2019 | Jun 02, 2019 |
| Anchor Lockin End date 2 | Nov 03, 2019 | Aug 01, 2019 |
Affle IPO P/E ratio is , as compared to Neogen Chemicals IPO P/E ratio of .
| Affle IPO | Neogen Chemicals IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 92.17 | |||||
| Promoter Shareholding (Post-Issue) | 68.4 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹1899.48 Cr. | ₹501.69 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Affle IPO Retail Individual Investors (RII) are offered 6,16,107 shares while in Neogen Chemicals IPO retail investors are offered 6,16,107 shares. Qualified Institutional Buyers (QIB) are offered 18,48,323 shares in Affle IPO and 12,31,191 shares in Neogen Chemicals IPO.
| Affle IPO | Neogen Chemicals IPO | |
|---|---|---|
| Anchor Investor Reservation | 27,72,483 shares | 18,46,715 shares |
| Market Maker Reservation | ||
| QIB | 18,48,323 shares | 12,31,191 shares |
| NII | 9,24,160 shares | 9,23,372 shares |
| RII | 6,16,107 shares | 21,54,535 shares |
| Employee | ||
| Others | ||
| Total | 61,61,073 shares | 61,55,813 shares |
Affle IPO subscribed 86.48x in total, whereas Neogen Chemicals IPO subscribed 41.07x.
| Affle IPO | Neogen Chemicals IPO | |
|---|---|---|
| QIB (times) | 55.31x | 30.49x |
| NII (times) | 198.69x | 113.88x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 10.94x | 15.86x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 86.48x | 41.07x |
